跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 310 条关于
“Bcl2”
全部
310
临床试验
181
药物
44
机构
0
资讯
85
2年前
Managing Toxicities in CLL Treatment: Expert Insights on BCL2 and BTK Inhibitor Selection
去年
Novel BTK-BCL2 Inhibitor Combination Shows Promise Against Drug-Resistant DLBCL with BCL10 Mutations
2年前
InnoCare Advances Dual Regulatory Milestones with Tafasitamab BLA Acceptance and BCL2 Inhibitor ICP-248 Clinical Trial Approval in China
去年
InnoCare's BCL2 Inhibitor ICP-248 Combination Therapy Advances to Phase III Trial for First-line CLL/SLL Treatment in China
2年前
BCL2 Protein Identified as Potential Drug Target in Aggressive Prostate Cancer
去年
Zanubrutinib and Venetoclax Combination Shows Promise in Relapsed/Refractory CLL
2个月前
Biomarker-Guided Drug Combinations May Overcome Treatment Resistance in Advanced Melanoma
去年
CCL2/CCR2 Pathway Identified as Key Driver of Aggression in Double-Expressor DLBCL
10个月前
Cancer Drug Venetoclax Shows 100% Efficacy in Preventing ALS Progression in Preclinical Study
去年
Venetoclax Enhances KRAS Inhibitor Efficacy in Pancreatic Cancer Models
第 1 页,共 9 页
上一页
下一页